Total physician sample (N) | 75 | 100.0% |
---|---|---|
Number of patients treated with advanced MTC in the last 12 months | ||
Mean (SD) | 26.0 (20.9) | |
Median (IQR) | 20.0 (8.0–45.0) | |
Primary medical specialty, (n, %) | ||
Medical or clinical oncology (oncologist) | 40 | 53.3% |
Hematology-oncology | 35 | 46.7% |
Primary practice setting, (n, %) | ||
Cancer center/tertiary referral treatment center | 34 | 45.3% |
Academic/teaching hospital | 13 | 17.3% |
Other nonteaching hospital | 3 | 4.0% |
Private hospital or clinic | 25 | 33.3% |
Number of years in practice managing treatment of oncology patients since fully qualified | ||
Mean (SD) | 14.7 (5.7) | |
Median (IQR) | 15.0 (10.0–18.0) | |
Geographic region of practice, (n, %) | ||
Northeast | 19 | 25.3% |
Midwest | 12 | 16.0% |
South | 23 | 30.7% |
West | 21 | 28.0% |
Number of patients for whom data was provided for this study | ||
Mean (SD) | 2.8 (2.0) | |
Median (IQR) | 2.0 (1.0-4.0) | |
Min, Max | 1.0 | 6.0 |